February 26, 2019
February 26, 2019
FDA Recalls Blood Pressure Medications for Possible Carcinogenic Contamination
It has been more than six months since the U.S. Food and Drug Administration (FDA) ordered several prescription blood pressure medications to be removed from pharmacy shelves due to the threat of contamination with an impurity known as N-nitrosodimethylamine (NDMA). The medications are a type of pharmacological product known as angiotensin II receptor blockers or […]